Malignant tumor of prostate
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age >=40 years, <=80 years; 2.Prostate biopsy confirms prostate cancer; 3.Clinical T stage <=T3a stage; 4.Fully understand clinical trial protocols and sign informed consent;
Exclusion criteria
Exclusion criteria: 1.Urinary incontinence before surgery; 2.Previous endoscopic prostate surgery; 3.There are serious underlying diseases that cannot tolerate surgery or have a survival of less than 5 years; 4.Metastatic disease is present or lymph node involvement is suspected at diagnosis; 5.Patients judged by the investigator to be unsuitable for participation in this clinical trial;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary control rate one month after catheter removal; | — |
Secondary
| Measure | Time frame |
|---|---|
| Urinary control rate one day after catheter removal;Urinary control rate one week after catheter removal;Surgical margins;Urinary control rate three months after catheter removal;Urinary control rate six months after catheter removal;Urinary control rate one year after catheter removal;Operation time;Estimated blood loss;Complications;Time for removal of drainage tube;Postoperative hospital stay; | — |
Countries
China
Contacts
The First Affiliated Hospital of Zhengzhou University